Skip to main content
. Author manuscript; available in PMC: 2021 Jun 29.
Published in final edited form as: J Vasc Surg. 2019 May 21;70(5):1543–1554. doi: 10.1016/j.jvs.2019.01.069

Table 2.

Presentation and management of arterial pathology in patients with vascular Ehlers-Danlos syndrome by artery involved. The % given is the percentage of all arterial pathology

Arteries N (%) % Male Median Age (IQR) Known vEDS diagnosis Missense mutation Dissection Aneurysm, Pseudoaneur ysm Rupture Medical Management Endovascular Embolization Endovascular Stenting Open Repair

Carotid N=17 (12.2) 5 (41.7) 27 (24–36) 4 (33.3) 8 (66.7) 6 (50) 5 (41.7), 1 (8.3) 0 100% 0 0 0
Vertebral N=6 (4.3) 2 (33.3) 27.5 (22–32.5) 3 (50) 5 (83.3) 4 (66.6) 1 (16.7) 0 100% 0 0 0

Celiac N=14 (10.5) 6 (40) 44 (33–50) 12 (80) 11 (73.3) 7 (46.7) 7 (46.7), 2 (13.3) 2 (13.3) 13 (86.7) 1 (6.7)* 0 1 (6.7)
Gastric N=3 (2.2) 0 37 (36–37) 2 (66.7) 2 (66.7) 1 (33.3) 0 0 3 (100) 0 0 0
Phrenic N=1 (0.7) 0 58 1 (100) 1 (100) 0 1 (100) 0 1 (100) 0 0 0
Splenic N=11 (7.9) 3 (27.3) 44 (31–51) 6 (54.5) 6 (54.5) 2 (18.2) 8 (72.7) 4 (36.4) 4 (36.4) 6 (54.5) 0 1 (9.4)
Hepatic N=8 (5.8) 5 (62.5) 47 (38.5–50.5) 5 (62.5) 4 (50) 0 7 (87.5), 1 (12.5) 1 12.5) 5 (62.5) 2 (25) 1 (12.5) (Figure 3) 0
Superior mesenteric N=6 (4.3) 1 (16.7) 45.5 (39–54.4) 5 (83.3) 3 (50) 2 (33.3) 2 (33.3) 1 (16.7) 5 (83.3) 1 (16.7)* 0 0

Renal N=17 (12.2) 12 (70.6) 37 (30.5–41) 9 (52.9) 13 (76.5) 7 (41.2) 8 (47.1), 1 (5.9) 0 14 (82.4) 1 (5.9) 0 2 (11.8)

Iliac N=23 (16.5) 18 (78.3) 41 (30–48) 12 (52.2) 19 (82.6) 7 (30.4) 16 (69.6) 1 (4.3) 17 (73.9) 1 (4.2) 2 (8.7) 3 (13)
Femoral N=2 (1.4) 1 (50) 27,33 0 2 (100) 1 1 0 1 0 0 1
Popliteal N=1 (0.7) 0 26 0 1 (100) 0 1 0 1 (100) 0 0 0
Posterior Tibial N=3 (2.2)** 2 (100) 19,32 1 (50) 1 (50) 0 3 0 2 0 0 1
*

Same individual, death due to multiple mesenteric arterial ruptures

**

One individual had bilateral posterior tibial arteries aneurysms